Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant Schizophrenia - P&T Community

Submitted by Anonymous (not verified) on Thu, 10/25/2018 - 15:23

Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant SchizophreniaP&T Communityii Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J; American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition.and more »